X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17855) 17855
Publication (1545) 1545
Book Review (1366) 1366
Newsletter (300) 300
Book Chapter (79) 79
Conference Proceeding (44) 44
Magazine Article (17) 17
Book / eBook (9) 9
Dissertation (6) 6
Data Set (2) 2
Web Resource (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15303) 15303
animals (8904) 8904
humans (6797) 6797
amides - pharmacology (6502) 6502
amides (4177) 4177
male (4111) 4111
pharmacology & pharmacy (3809) 3809
rats (3765) 3765
chemistry, medicinal (3606) 3606
mice (2972) 2972
amides - chemistry (2817) 2817
structure-activity relationship (2580) 2580
female (2262) 2262
biochemistry & molecular biology (2255) 2255
pyridines - pharmacology (1782) 1782
amides - chemical synthesis (1767) 1767
enzyme inhibitors - pharmacology (1661) 1661
chemistry, organic (1627) 1627
molecular structure (1529) 1529
dose-response relationship, drug (1491) 1491
analysis (1436) 1436
acid amide hydrolase (1196) 1196
research (1075) 1075
neurosciences (1032) 1032
cells, cultured (968) 968
models, molecular (920) 920
in vitro techniques (914) 914
rats, sprague-dawley (913) 913
kinetics (906) 906
chemistry, multidisciplinary (904) 904
endocannabinoids (897) 897
article (895) 895
cell biology (860) 860
cell line, tumor (856) 856
cell line (849) 849
enzymes (847) 847
time factors (826) 826
pharmacology (819) 819
adult (787) 787
drug design (785) 785
anandamide (775) 775
derivatives (772) 772
proteins (769) 769
amides - therapeutic use (768) 768
chemistry (766) 766
in-vitro (710) 710
cells (706) 706
expression (694) 694
rats, wistar (694) 694
activation (692) 692
amides - metabolism (692) 692
middle aged (692) 692
physiological aspects (681) 681
cancer (669) 669
inhibition (668) 668
amide (660) 660
antineoplastic agents - pharmacology (638) 638
amides - administration & dosage (636) 636
inhibitors (631) 631
ligands (624) 624
stereoisomerism (586) 586
abridged index medicus (581) 581
magnetic resonance spectroscopy (581) 581
rho-associated kinases - antagonists & inhibitors (570) 570
old medline (559) 559
disease models, animal (557) 557
fatty acids (557) 557
binding sites (553) 553
brain (548) 548
multidisciplinary sciences (544) 544
apoptosis (543) 543
phosphorylation (538) 538
lipids (534) 534
peptides (528) 528
physiology (525) 525
amino acid sequence (514) 514
design (512) 512
endocrinology & metabolism (508) 508
drugs (500) 500
cell proliferation - drug effects (495) 495
rho-associated kinases (495) 495
hydrolysis (492) 492
signal transduction (490) 490
protein binding (489) 489
in-vivo (479) 479
metabolism (476) 476
rodents (476) 476
microbial sensitivity tests (469) 469
binding (468) 468
endocannabinoid system (468) 468
mice, inbred c57bl (467) 467
rabbits (467) 467
cell survival - drug effects (462) 462
molecular sequence data (456) 456
inhibitory concentration 50 (454) 454
receptor (454) 454
aged (452) 452
chemical phenomena (448) 448
medicine (448) 448
blood pressure - drug effects (445) 445
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17080) 17080
German (421) 421
Japanese (191) 191
Russian (132) 132
French (119) 119
Italian (94) 94
Polish (65) 65
Chinese (52) 52
Spanish (34) 34
Ukrainian (14) 14
Czech (13) 13
Portuguese (11) 11
Turkish (6) 6
Bulgarian (5) 5
Hungarian (5) 5
Dutch (3) 3
Croatian (2) 2
Danish (2) 2
Romanian (2) 2
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 01/2008, Volume 35, Issue 1, pp. 29 - 34
SUMMARY • The aim of the present study was to determine whether inhibition of dipeptidyl peptidase IV (DPP IV) elevates arterial blood pressure and whether any... 
3-N-[(2S,3S)-2-amino-3-methylpentanoyl]-1,3-thiazolidine | N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-d-arginine amide | P32/98 | Wistar-Kyoto rat | neuropeptide Y | dipeptidyl peptidase IV | spontaneously hypertensive rat | Y1 receptor | BIBP 3226 | peptide YY | [(2S,3S)‐2‐amino‐3‐methylpentanoyl]‐1,3‐thiazolidine | receptor | (4‐hydroxyphenyl)methyl | Wistar‐Kyoto rat | 2‐(diphenylacetyl) | arginine amide | BIBP 3226 | Neuropeptide Y | Spontaneously hypertensive rat | N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D- arginine amide | Peptide YY | Dipeptidyl peptidase IV | PHYSIOLOGY | SPONTANEOUSLY HYPERTENSIVE-RATS | NHE3 | NEUROPEPTIDE-Y | N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D-arginine amide | PHARMACOLOGY & PHARMACY | RECEPTORS | NORADRENALINE | Y-1 receptor | GLUCOSE-TOLERANCE | VASOCONSTRICTION | Antihypertensive Agents - pharmacology | Dipeptidyl Peptidase 4 - metabolism | Captopril - pharmacology | Hydralazine - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Rats, Inbred WKY | Receptors, Neuropeptide Y - metabolism | Hypertension - drug therapy | Ganglionic Blockers - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Arginine - analogs & derivatives | Dose-Response Relationship, Drug | Drug Interactions | Receptors, Neuropeptide Y - drug effects | Pentanoic Acids - pharmacology | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Blood Pressure - drug effects | Hypertension - enzymology | Hypertension - genetics | Thiazolidines - pharmacology | Disease Models, Animal | Chlorisondamine - pharmacology | Rats, Inbred SHR | Vasodilator Agents - pharmacology | Rats | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Animals | Arginine - pharmacology | Receptors, Neuropeptide Y, drug effects | Antihypertensive Agents, therapeutic use | Hypertension, enzymology | Arginine, pharmacology | Hypertension, drug therapy | Arginine, analogs and derivatives | Hypertension, genetics | Pentanoic Acids, pharmacology | Captopril, pharmacology | Vasodilator Agents, pharmacology | Ganglionic Blockers, pharmacology | Hypertension, physiopathology | Blood Pressure, drug effects | Dipeptidyl-Peptidase IV Inhibitors, therapeutic use | Angiotensin-Converting Enzyme Inhibitors, pharmacology | Antihypertensive Agents, pharmacology | Chlorisondamine, pharmacology | Receptors, Neuropeptide Y, metabolism | Hydralazine, pharmacology | Dipeptidyl-Peptidase IV Inhibitors, pharmacology | Thiazolidines, pharmacology | Antigens, CD26, metabolism | Antigens, CD26, antagonists and inhibitors | Hypertension | Blood pressure | Captopril | Analysis | Index Medicus
Journal Article
Journal Article
Anesthesia and Analgesia, ISSN 0003-2999, 02/2013, Volume 116, Issue 2, pp. 463 - 472
BACKGROUND: Cannabinoid agonists induce norepinephrine release in central, spinal, and peripheral sites. Previous studies suggest an interaction between the... 
NEUROPATHIC PAIN | INFLAMED TISSUE | RAT FRONTAL-CORTEX | ALPHA-2-ADRENOCEPTOR SUBTYPES | FATTY-ACID AMIDE | SPINAL-CORD | ANESTHESIOLOGY | NONCATECHOLIC PHENYLETHYLAMINE DERIVATIVES | NOREPINEPHRINE RELEASE | FORMALIN TEST | DORSAL-ROOT GANGLION | Analgesics - pharmacology | Ethanolamines - pharmacology | Endocannabinoids - pharmacology | Rats, Wistar | Receptor, Cannabinoid, CB2 - agonists | Norepinephrine - physiology | Sympathetic Nervous System - drug effects | Dinoprostone | Male | Cannabinoid Receptor Agonists - pharmacology | Peripheral Nerves - drug effects | Yohimbine - pharmacology | Adrenergic beta-Antagonists - pharmacology | Propranolol - pharmacology | Receptor, Cannabinoid, CB1 - agonists | Adrenergic alpha-1 Receptor Antagonists - pharmacology | Prazosin - pharmacology | Palmitic Acids - pharmacology | Palmitic Acids - antagonists & inhibitors | Morpholines - pharmacology | Rats | Pain Measurement - drug effects | Ethanolamines - antagonists & inhibitors | Polyunsaturated Alkamides - antagonists & inhibitors | Adrenergic alpha-2 Receptor Antagonists - pharmacology | Arachidonic Acids - pharmacology | Animals | Arachidonic Acids - antagonists & inhibitors | Polyunsaturated Alkamides - pharmacology | Adrenergic Uptake Inhibitors - pharmacology | Endocannabinoids - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Molecular Pharmacology, ISSN 0026-895X, 03/2008, Volume 73, Issue 3, pp. 789 - 800
In addition to being an important receptor in leukocyte activation and mobilization, CCR5 is the essential coreceptor for human immunodeficiency virus (HIV). A... 
AMINO-TERMINAL DOMAIN | PROTEIN | ENTRY | CORECEPTOR | RECEPTOR ANTAGONISTS | IMMUNODEFICIENCY-VIRUS TYPE-1 | ANTI-HIV-1 ACTIVITY | PHARMACOLOGY & PHARMACY | HIGHLY POTENT | INHIBITOR | BINDING | Anti-HIV Agents - pharmacology | Benzoates - metabolism | Humans | Receptors, CCR5 - genetics | Piperazines - chemistry | Pyrimidines - metabolism | Receptors, CCR5 - metabolism | Piperidines - pharmacology | Amides - metabolism | Anti-HIV Agents - metabolism | Radioligand Assay | Binding Sites | Amides - pharmacology | Anti-HIV Agents - classification | Amino Acid Sequence | Piperidines - metabolism | Models, Molecular | Pyrimidines - pharmacology | HIV Fusion Inhibitors - pharmacology | Piperazines - pharmacology | Triazoles - metabolism | Anti-HIV Agents - chemistry | Amides - chemistry | Benzoates - pharmacology | Hydrophobic and Hydrophilic Interactions | Receptors, CCR5 - chemistry | Quaternary Ammonium Compounds - pharmacology | Cricetulus | Triazoles - chemistry | Benzoates - chemistry | Cyclohexanes - pharmacology | Molecular Sequence Data | Piperazines - metabolism | Quaternary Ammonium Compounds - chemistry | Pyrimidines - chemistry | Cyclohexanes - metabolism | Transfection | Inhibitory Concentration 50 | Cyclohexanes - chemistry | Molecular Structure | Membrane Fusion - drug effects | Spiro Compounds - chemistry | CCR5 Receptor Antagonists | CHO Cells | Protein Structure, Tertiary | Cricetinae | Piperidines - chemistry | Mutagenesis, Site-Directed | Protein Structure, Secondary | HIV-1 - drug effects | Static Electricity | Sequence Homology, Amino Acid | Triazoles - pharmacology | Animals | Quaternary Ammonium Compounds - metabolism | Spiro Compounds - pharmacology | Spiro Compounds - metabolism | Index Medicus
Journal Article
Hippocampus, ISSN 1050-9631, 10/2017, Volume 27, Issue 10, pp. 1093 - 1109
Exposure to excessive or uncontrolled stress is a major factor associated with various diseases including posttraumatic stress disorder (PTSD). The... 
URB597 | LTP | CB1 | extinction | posttraumatic stress disorder (PTSD) | receptors | CONDITIONED TASTE-AVERSION | BASOLATERAL AMYGDALA | CONTEXTUAL FEAR | ENDOCANNABINOID SYSTEM | EMOTIONAL MEMORY | SYNAPTIC PLASTICITY | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | GLUCOCORTICOID-RECEPTOR ACTIVATION | CB1 RECEPTOR | PITUITARY-ADRENAL AXIS | Cannabinoid Receptor Modulators - pharmacology | Memory - drug effects | Amygdala - physiopathology | Amygdala - drug effects | Stress Disorders, Post-Traumatic - pathology | Fear - drug effects | Neuronal Plasticity - drug effects | Male | Hippocampus - drug effects | Stress Disorders, Post-Traumatic - physiopathology | Fear - physiology | Receptors, Cannabinoid - metabolism | Neuronal Plasticity - physiology | Piperidines - pharmacology | Stress Disorders, Post-Traumatic - drug therapy | Benzamides - pharmacology | Carbamates - pharmacology | Disease Models, Animal | Pyrazoles - pharmacology | Amidohydrolases - metabolism | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Amidohydrolases - antagonists & inhibitors | Hippocampus - pathology | Stress Disorders, Post-Traumatic - psychology | Avoidance Learning - physiology | Magnesium - pharmacology | Rats, Sprague-Dawley | Amygdala - pathology | Cannabinoids - pharmacology | Naphthalenes - pharmacology | Animals | Benzoxazines - pharmacology | Glutamates - pharmacology | Avoidance Learning - drug effects | Bromine - pharmacology | Electroshock | Hippocampus - physiopathology | Drug Combinations | Memory - physiology | Prevention | Phenols | Cannabinoids | Fatty acids | Analysis | Post-traumatic stress disorder | Potentiation | Fatty-acid amide hydrolase | Shock | Amygdala | Hydrolase | Extinction | Long-term potentiation | Taste aversion | Cannabinoid CB1 receptors | Plasticity (hippocampal) | Trauma | Animal behavior | Rodents | Aversion | Short term memory | Hippocampus | Long-term effects | Index Medicus
Journal Article